TP

The Pharmacogenomics Journal

The Pharmacogenomics Journal is a Nature journal focused on pharmacogenomics research and publishes article formats including Articles, Review Articles, and Perspectives.

Looking to publish in The Pharmacogenomics Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Genetics & Heredity, Pharmacology & Pharmacy
Impact Factor 2.9
Quartile Q2
Open Access Type Hybrid
ISSN 1470-269X
eISSN 1473-1150
Invitation Only No
Cost Range £3190.00 / $5090.00 / €3990.00 APC, subject to VAT or local taxes where applicable.

Submission Instructions

The Pharmacogenomics Journal accepts the following article types. Click on an article type to view submission instructions.

Article

Cover Letter A cover letter is required. Cover letter must provide the corresponding author's affiliation and contact information, briefly explain the importance of the work and its suitability for the journal's diverse readership, confirm originality, and include a Competing Interests statement.
Abstract An abstract is required. Abstract must be unstructured and must not exceed 150 words. Abstract must be unstructured.
Manuscript Main body text excluding the abstract, tables/figures, and references must not exceed 3,500 words. Manuscript should include Materials/Subjects and Methods, Results, Discussion, and a final Discussion paragraph stating the main conclusions and future research directions. Manuscript must include a Data Availability Statement and any use of an LLM must be documented in the Methods section or another suitable section if Methods is unavailable.
References Article must include no more than 80 references. References must follow Vancouver format. References must be cited in the text as numbered citations starting at 1 and listed in numerical order, with up to six authors listed in full and additional authors abbreviated as et al.
Figures & Tables Article must include no more than 8 tables or figures. Figures must be uploaded as separate files rather than embedded in the text, while each table must be uploaded as a separate editable file. Tables must be editable and sequentially labelled with titles or captions, and figure legends must be brief, specific, and provided on a separate manuscript page after the References section.
Reformat to The Pharmacogenomics Journal using Livewrite Premium

Review Article

Cover Letter A cover letter is required. Cover letter must include the corresponding author's affiliation and contact information, briefly discuss the importance of the work, explain its suitability for the journal's diverse readership, confirm originality, and include a Competing Interests statement.
Abstract An abstract is required. Abstract must be unstructured and must not exceed 150 words. Abstract must be unstructured.
Manuscript Main body text, excluding abstract, tables/figures, and references, must not exceed 4,000 words. The manuscript must include Materials/Subjects and Methods and a Discussion whose final paragraph states the main conclusion or conclusions and indicates directions for future research. Authors must include an author contributions statement, a Competing Interests statement before the References section under 'Competing Interests', and documentation of any LLM use in the Methods section or another suitable part of the manuscript if no Methods section is available.
References The manuscript must include no more than 100 references. References must follow Vancouver format. References must be numbered in order of citation, listed in numerical order, list all authors if there are up to six and the first six followed by et al. if there are more than six, and include first and last page numbers.
Figures & Tables Figures must not be embedded in the text and must be uploaded as separate files, while each table must be uploaded as a separate editable file. Tables must be editable, titled, sequentially labelled, and cited in order in the text, and figure legends must be brief, specific, and placed on a separate manuscript page after the References section.
Reformat to The Pharmacogenomics Journal using Livewrite Premium

Correspondence

Cover Letter Cover letter is required. Cover letter must include the corresponding author's affiliation and contact information, briefly discuss the importance of the work, explain its suitability for the journal's diverse readership, confirm originality and exclusive submission, and include a Competing Interests statement.
Abstract Abstract is not required.
Manuscript Main body text, excluding tables or figures and references, must not exceed 900 words. Manuscript must begin with a two- or three-sentence opening paragraph that conveys the article's message without specialized terminology. Any use of an LLM must be documented in a suitable part of the manuscript because a Methods section may not be available.
References No more than 10 references are allowed. References must follow Vancouver format. In-text citations must be numbered starting at 1 and the reference list must be in numerical order of citation, listing all authors up to six and the first six followed by et al. when there are more than six authors.
Figures & Tables No more than 1 table or figure is allowed. Figures must not be embedded in the text and must be uploaded as separate files, and each table must be uploaded separately. Tables must be editable and each figure and table must be labeled sequentially, cited in order in the text, and accompanied by a caption or legend.
Reformat to The Pharmacogenomics Journal using Livewrite Premium

Perspective

Cover Letter Cover letter is required. Cover letter must provide the corresponding author's affiliation and contact information, briefly explain the importance of the work and its suitability for the journal's diverse readership, confirm originality, include a Competing Interests statement, and include prior reviewer comments if the manuscript was previously considered by another journal.
Abstract Abstract is not required.
Manuscript Main body text excluding tables, figures, and references must not exceed 2,000 words. Any use of an LLM must be documented in the Methods section or, if no Methods section is available, in a suitable alternative part of the manuscript.
References No more than 30 references are permitted. References must follow Vancouver format. In-text citations must be numbered consecutively from 1 and the reference list must be double-spaced in numerical order, listing all authors up to six and the first six followed by et al. for more than six.
Figures & Tables No more than 2 tables or figures are permitted. Figures must be uploaded as separate files rather than embedded in the text, and each table must be uploaded as a separate file. Figure legends must appear on a separate manuscript page after the References section, and each table and figure must be sequentially labelled and cited in the text.
Reformat to The Pharmacogenomics Journal using Livewrite Premium

Recent Publications

Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants

Amy L. Pasternak, William Tackett, Mousumi Banerjee, Simi Paul, Emily Bertucci-Richter, Xiang Zhou, Vaibhav Sahai, Daniel L. Hertz

10.1038/s41397-026-00432-2
View Publication

Bridging the pharmacogenomics gap: a survey of healthcare workers in South-Western Nigeria

Ochuko M. Orherhe, Omolabake F. Ayodele, Jeremiah O. Omojuyigbe, Ayodapo O. Jegede, Olumide A. Alade, Kikelomo Oladimeji, Oluwatimilehin S. Ogunde, Promise U. Okereke, Oluwafemi O. Agboola, Moteehat O. Olu-Lawal, Olusanya Aluko, Babatunde A. Adeagbo, Oluseye O. Bolaji

10.1038/s41397-026-00433-1
View Publication

The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine

Najmeh Ahangari, Mohammad Doosti, Mojtaba Safi, Narges Hashemi, Shima Imannezhad, Bita Barazandeh, Ehsan Ghayoor Karimiani, Mehran Beiraghi Toosi

10.1038/s41397-026-00430-4
View Publication

Risk of drug-induced liver injury in multiple system atrophy patients treated with KM-819 is potentially associated with the HLA-DPB1*05:01:01:01 allele

Jeong-Hoon Han, Raúl J. Andrade, Einar Stefán Björnsson, James Hendricks Lewis, M. Isabel Lucena, Suyoung Go, Simona Stankeviciute, Guruprasad P. Aithal, Kyuchan Kim, Chong Sik Lee, Carrolee Barlow, Eunhee Kim

10.1038/s41397-026-00431-3
View Publication

Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research

Muireann Counihan, Deirdre Cushen, Sookyung Kwak, Amy Allen, Donnchadh Fitzsimons Mac Giolla Chuda, Weronika Romanska, Ibrahim Nakchbandi, Rose Reynolds, Chad Bousman, Mark Ledwidge, Joseph Gallagher, Cristín Ryan

10.1038/s41397-026-00426-0
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first editorial decision (median days): 4. Submission to acceptance (median days): 283.

Reformat to The Pharmacogenomics Journal using Livewrite Premium

Is a cover letter required?

A cover letter is required and should include the corresponding author’s affiliation and contact information, the importance of the work, why it is appropriate for the journal’s readership, confirmation that the work is original, not previously published, and not under consideration elsewhere, prior reviewer comments if previously considered by another journal, and a competing interests statement.

Reformat to The Pharmacogenomics Journal using Livewrite Premium

What are the publication costs?

Open access publication requires an APC of £3190.00 / $5090.00 / €3990.00, subject to VAT or local taxes where applicable.

Reformat to The Pharmacogenomics Journal using Livewrite Premium

Research Topics

Pharmacogenetics and Drug Metabolism Drug Transport and Resistance Mechanisms Genetic Associations and Epidemiology Pharmacological Effects and Toxicity Studies Colorectal Cancer Treatments and Studies Computational Drug Discovery Methods Receptor Mechanisms and Signaling Acute Lymphoblastic Leukemia research Genomics and Rare Diseases Neurotransmitter Receptor Influence on Behavior Pharmaceutical studies and practices Bipolar Disorder and Treatment Hormonal Regulation and Hypertension Schizophrenia research and treatment HIV/AIDS drug development and treatment Gene expression and cancer classification Renal Transplantation Outcomes and Treatments Diabetes Treatment and Management Cancer therapeutics and mechanisms Bioinformatics and Genomic Networks Asthma and respiratory diseases Rheumatoid Arthritis Research and Therapies Lipoproteins and Cardiovascular Health Genetic factors in colorectal cancer Epigenetics and DNA Methylation

Related Journals

TA
Therapeutic Advances in Chronic Disease SAGE Publishing
EO
Expert Opinion on Drug Safety Taylor & Francis
CT
Clinical Therapeutics Elsevier BV
TA
Therapeutic Advances in Drug Safety SAGE Publishing
Al
Alcohol Elsevier BV
HR
Hypertension Research Springer Nature